LISATA THERAPEUTICS, INC. Number of Reporting Units
LISATA THERAPEUTICS, INC. (LSTA) reported Number of Reporting Units of 2 reporting_unit for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-22.
Discontinued › Notes
us-gaap:NumberOfReportingUnits · last filed 2018-03-22
- LISATA THERAPEUTICS, INC. number of reporting units for the quarter ending 2015-06-30 was 2.00 reporting_unit.
- LISATA THERAPEUTICS, INC. number of reporting units for fiscal 2016 was 2.00 reporting_unit, a 0.00% change from fiscal 2015.
- LISATA THERAPEUTICS, INC. number of reporting units for fiscal 2015 was 2.00 reporting_unit, a 0.00% change from fiscal 2014.
- LISATA THERAPEUTICS, INC. number of reporting units for fiscal 2014 was 2.00 reporting_unit.
| Period end | Number of Reporting Units 3 month | Number of Reporting Units 12 month |
|---|---|---|
| 2016-12-31 | 2.00 reporting_unit 10-K · filed 2018-03-22 | |
| 2015-12-31 | 2.00 reporting_unit 10-K · filed 2017-03-17 | |
| 2015-06-30 | 2.00 reporting_unit 10-K · filed 2018-03-22 | |
| 2014-12-31 | 2.00 reporting_unit 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |